Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.5 USD | +0.68% | -2.32% | -10.17% |
May. 13 | US reclassification could drive fresh research funding into pot sector | RE |
May. 07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.17% | 6.97B | |
+32.36% | 694B | |
+30.00% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.35% | 239B | |
+10.31% | 209B | |
-3.27% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures